A single screen can yield thousands of drug candidates.

Texas A&M researchers are training machine learning to flag which tuberculosis compounds are worth pursuing, cutting costly dead ends in a disease concentrated across South Asia and Africa.

Chemist James Sacchettini’s team is refining which screening signals the models should trust most.

Sources: Phys.org